Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens

Abstract Background Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR TKIs) are established first-line treatments among patients with metastatic non-small cell lung cancer harboring EGFR-sensitizing mutations. Upon EGFR TKI resistance, there are scant data supporting a standard of ca...

Full description

Saved in:
Bibliographic Details
Main Authors: Elizabeth Marrett (Author), Winghan Jacqueline Kwong (Author), Jipan Xie (Author), Ameur M. Manceur (Author), Selvam R. Sendhil (Author), Eric Wu (Author), Raluca Ionescu-Ittu (Author), Janakiraman Subramanian (Author)
Format: Book
Published: Adis, Springer Healthcare, 2023-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available